Starting next week, on the 16th, and extending for 2 mores sessions on the 18th and 22nd of February, the online training course on Regulatory and Scientific Pathways for Global Advanced Therapies Medicinal Products Development aims to give a broad scientific and regulatory overview of the current state of the art and challenges faced by ATMP development.
The event is organized by Life Science Academy and the lecturers will be Nuria Coderch, Marta Rayo Lunar and Chris Mann from Asphalion.
Advanced therapy medicinal products (ATMPs) are currently undergoing a boom. Several products including viral, non-viral and cell-based products have forged a path to market. In their wake, academics and clinicians continue to lead innovation and unlock the clinical potential of new approaches and technologies, whereas increased industry interest is stimulating investment and industrialization of the processes that lead to commercialization.
The program will follow the life cycle of an ATMP from concept to clinic and commercialization. and it will take into consideration global regulatory requirements and the often-challenging regulatory problems that ATMPs face.
The online training course is aimed at Regulatory Affairs managers, officers and specialists, development pharmacists and project managers working for pharmaceutical company, Biotech, spin-offs and CROs. It is also addressed to researchers an academics in the ATMP field.
If you are interested in this Regulatory and Scientific Pathways for Global Advanced Therapies Medicinal Products Development course you can register here.
For further information, please contact us at: email@example.com